Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Elizabeth Yeu-Lin, Hawaiian Eye 2021: Managing Toric Intraocular Lens Surprises

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 21st 2021

We were delighted to speak with Editor-in-Chief, Elizabeth Yeu-Lin (Eastern Virginia Medical School, Norfolk, VA, USA) about her talk on managing toric intraocular lens surprises.

Question

  1. What options are available for the management toric intraocular lens surprises, and what factors should be considered when selecting the appropriate course of action? (00:18)

Speaker Disclosure: Elizabeth Yeu-Lin has no financial or non-financial relationships or activities to declare in relation to this interview.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Helen Fowler.

Filmed in coverage of Hawaiian Eye and Retina 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup